Global Sterile Tubing Welder Market 2023-2030

Description

List of Tables

Global Sterile Tubing Welder Market Size, Share & Trends Analysis Report by Mode (Manual and Automatic), By Application, (Biopharmaceutical, Blood Processing, Diagnostic Laboratories, and Others), and by End-use (Hospitals, Blood Centers, and Others), Forecast Period (2023-2030)

The global sterile tubing welder market is anticipated to grow at a CAGR of 5.6% during the forecast period (2023-2030). The primary factor supporting the demand for the global sterile tubing welder market globally includes the rising usage of single-use technologies and increasing demand for blood and blood products due to increasing cases of blood cancer, anemia, hemophilia, and more are anticipated to further boost the market growth. According to the World Federation of Hemophilia Survey 2022, number of people identified with Hemophilia were 257,146, people with hemophilia A were 208,957, people with hemophilia B were 42,203, and the people with hemophilia type unknown or type not reported 5,986.

Further, in November 2022, the article "Senior Population Statistics: A Portrait of Aging Americans", reported 54.1 million adults or 16.3% of the US population are seniors including aged 65 years and above. The senior population is expected to rise to 22.0% by 2040 and 25.0% by 2060. In contrast, entrance of a new technical advancement to replace the tub welder hinder the sterile tubing welder market growth. In September 2021, Colder Products Co., part of Dover, launched a new ultra-compact sterile connector providing biopharmaceutical manufacturers a much-required alternative to tube welding for their small-volume closed aseptic processes. MicroCNX™ Series Connectors are the industry's first aseptic connectors designed to provide a simple, efficient method of connecting tubing in small-format assemblies.

Segmental Outlook

The global sterile tubing welder market is segmented by mode, application, and end-use. Based on the mode, the market is sub-segmented into manual and automatic. Based on the application, the market is sub-segmented into biopharmaceutical, blood processing, diagnostic laboratories, and others. Further, based on end-use, the market is sub-segmented into hospitals, blood centers, and others. Where others include research clinics. Among the mode, the automatic sub-segment is anticipated to hold the largest market share during the forecast period, owing to the reducing the need for manual labor and improving production throughput, and cost-effectiveness.

Hospitals Sub-Segment is Anticipated to Hold a Considerable Share of the Global Sterile Tubing Welder Market

Among the end-use, hospitals sub-segment expected to grow over the forecast period. In hospitals, the growing adoption of sophisticated devices to reduce patient turnaround time and meet the increasing demand. The use of complex, sophisticated devices have, in turn, led hospitals to reevaluate sterile processing departments and equipment to meet the infection control standard. Transfusion committees in hospitals are anticipated to ensure the use of sterile equipment for quality transfusions and patient safety. According to World Health Organization 2023, 48.0% of the hospitals performing transfusions have a transfusion committee, with 62.0% of those in hospitals in high-income countries, 35.0% in upper-middle-income countries, 31 in lower-middle-income countries and 25.0% in low-income countries. In high-income countries, the most frequently transfused patient group is over 60 years of age, which accounts for up to 76.0% of all transfusions. In low-income countries, up to 54.0% of transfusions are for children under the age of 5 years. Such statistics project that the needs will increase the demand for sterile tubing welders over the forecast period.

Regional Outlook

The global sterile tubing welder market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the European region is anticipated to grow over the forecast period, owing to the increasing geriatric population, increasing prevalence of anemia, the rising healthcare expenditure, driving the sterile tubing welder market in Europe.

The North America Region is Expected to Grow at a Significant CAGR in the Global Sterile Tubing Welder Market

North America is expected to hold a prominent share in the sterile tubing welder market during the forecast period. The significant factors fueling the North America market is the rising prevalence of hemophilia across the North America is estimated to positively impact the sterile tubing welder market growth in upcoming years. According to the Centers for Disease Control and Prevention (CDC), the estimated prevalence of hemophilia only in the US is 12 cases per 100,000 US males for hemophilia A and 3.7 cases per 100,000 US males for hemophilia B. Furthermore, the estimated incidence of hemophilia among US births is 1 birth/ 5,617 male births for hemophilia A in birth/ 19,238 male births for hemophilia B. Such conditions such as hemophilia A result from the absence or deficiency of Factor VIII (FVIII).

Market Players Outlook

The major companies serving the global sterile tubing welder market include Cytiva (Life Sciences Solutions USA LLC), Genesis BPS, Sartorius AG, Terumo BCT, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2022, Colder Products Co., launched the new AseptiQuik G DC Series Connector designed to simplify closed-system liquid processing for biopharmaceutical manufacturers with the ability to connect and disconnect tubing aseptically using a single, sterile connection technology.

The Report Covers:

Market value data analysis of 2022 and forecast to 2030.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global sterile tubing welder market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2027959

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis
3.2. Cytiva (Life Sciences Solutions USA LLC)
- 3.2.1. Overview
- 3.2.2. Financial Analysis
- 3.2.3. SWOT Analysis
- 3.2.4. Recent Developments
3.3. Genesis BPS
- 3.3.1. Overview
- 3.3.2. Financial Analysis
- 3.3.3. SWOT Analysis
- 3.3.4. Recent Developments
3.4. Sartorius AG
- 3.4.1. Overview
- 3.4.2. Financial Analysis
- 3.4.3. SWOT Analysis
- 3.4.4. Recent Developments
3.5. Terumo BCT, Inc.
- 3.5.1. Overview
- 3.5.2. Financial Analysis
- 3.5.3. SWOT Analysis
- 3.5.4. Recent Developments
3.6. Key Strategy Analysis

4. Market Segmentation

4.1. Global Sterile Tubing Welder Market by Mode
- 4.1.1. Manual
- 4.1.2. Automatic
4.2. Global Sterile Tubing Welder Market by Application
- 4.2.1. Biopharmaceutical
- 4.2.2. Blood Processing
- 4.2.3. Diagnostic Laboratories
- 4.2.4. Others (blood collection)
4.3. Global Sterile Tubing Welder Market by End-Use
- 4.3.1. Hospitals
- 4.3.2. Blood Centers
- 4.3.3. Others (Research Clinics)

5. Regional Analysis

5.1. North America
- 5.1.1. United States
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. MGA Technologies
6.2. GE HealthCare Technologies Inc
6.3. Vante Biopharm / Sebra
6.4. Biomen Biosystems Co., Ltd.
6.5. Syngen Iberica, S.L.U.
6.6. Sentinel Process Systems, Inc.
6.7. Entegris, Inc. (Flex Concepts)
6.8. Shanghai Le Pure Biological Technology Co., Ltd.
6.9. Entegris, Inc.
6.10. Saint-Gobain Group
6.11. NewAge Industries
6.12. Aseptic group